Laquinimod [CAS 248281-84-7]
Partner: MedChemexpress LLC
CAS No: | 248281-84-7 |
Applications: | COVID-19-immunoregulation |
MW: | 356.80 |
Formula: | C19H17ClN2O3 |
SMILES: | O=C(C1=C(O)C2=C(N(C)C1=O)C=CC=C2Cl)N(CC)C3=CC=CC=C3 |
Purity: | 99.96 |
Description: | Laquinimod (ABR-215062), an orally available carboxamide derivative, is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system. Laquinimod reduces astrocytic NF-?B activation to protect from Cuprizone-induced demyelination. Laquinimod has�the�potential�for relapsing remitting (RR) and chronic progressive (CP) forms of multiple sclerosis (MS; RRMS or CPMS) as well as neurodegenerative diseases�research[1][2][3][4]. |
Shipping Conditions: | Ship at ambient |
Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice